BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33022644)

  • 1. Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Deininger MW; Shah NP; Altman JK; Berman E; Bhatia R; Bhatnagar B; DeAngelo DJ; Gotlib J; Hobbs G; Maness L; Mead M; Metheny L; Mohan S; Moore JO; Naqvi K; Oehler V; Pallera AM; Patnaik M; Pratz K; Pusic I; Rose MG; Smith BD; Snyder DS; Sweet KL; Talpaz M; Thompson J; Yang DT; Gregory KM; Sundar H
    J Natl Compr Canc Netw; 2020 Oct; 18(10):1385-1415. PubMed ID: 33022644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
    Shah NP; Bhatia R; Altman JK; Amaya M; Begna KH; Berman E; Chan O; Clements J; Collins RH; Curtin PT; DeAngelo DJ; Drazer M; Maness L; Metheny L; Mohan S; Moore JO; Oehler V; Pratz K; Pusic I; Rose MG; Shomali W; Smith BD; Styler M; Talpaz M; Tanaka TN; Tantravahi S; Thompson J; Tsai S; Vaughn J; Welborn J; Yang DT; Sundar H; Gregory K
    J Natl Compr Canc Netw; 2024 Feb; 22(1):43-69. PubMed ID: 38394770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology.
    Radich JP; Deininger M; Abboud CN; Altman JK; Berman E; Bhatia R; Bhatnagar B; Curtin P; DeAngelo DJ; Gotlib J; Hobbs G; Jagasia M; Kantarjian HM; Maness L; Metheny L; Moore JO; Pallera A; Pancari P; Patnaik M; Purev E; Rose MG; Shah NP; Smith BD; Snyder DS; Sweet KL; Talpaz M; Thompson J; Yang DT; Gregory KM; Sundar H
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1108-1135. PubMed ID: 30181422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular
    Marin AM; Wosniaki DK; Sanchuki HBS; Munhoz EC; Nardin JM; Soares GS; Espinace DC; de Holanda Farias JS; Veroneze B; Becker LF; Costa GL; Beltrame OC; de Oliveira JC; Cambri G; Zanette DL; Aoki MN
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient.
    Zámečníkova A; Al Bahar S; Pandita R
    Hematology; 2012 Nov; 17(6):321-4. PubMed ID: 22989955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
    Luatti S; Baldazzi C; Marzocchi G; Ameli G; Bochicchio MT; Soverini S; Castagnetti F; Tiribelli M; Gugliotta G; Martinelli G; Baccarani M; Cavo M; Rosti G; Testoni N
    Oncotarget; 2017 May; 8(18):29906-29913. PubMed ID: 28404889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring.
    Jabbour E; Kantarjian H
    Am J Hematol; 2020 Jun; 95(6):691-709. PubMed ID: 32239758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
    Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?
    Rumpold H; Webersinke G
    Curr Cancer Drug Targets; 2011 Jan; 11(1):3-19. PubMed ID: 21062244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia].
    Usui N
    Rinsho Byori; 2004 Feb; 52(2):136-44. PubMed ID: 15027317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique three-way Philadelphia chromosome variant t(4;9;22)(q21;q34;q11.2) in a newly diagnosed patient with chronic phase chronic myeloid leukemia: a case report and review of the literature.
    Torii Y; Nanjo K; Toubai T; Hosokawa M; Sato R; Yamada A; Aizawa K; Himuro M; Ito S; Yamamoto M; Magenau J; Wilcox R; Ishizawa K
    J Med Case Rep; 2021 May; 15(1):285. PubMed ID: 34030730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
    Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
    Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.
    Moore FR; Yang F; Press RD
    Methods Mol Biol; 2013; 999():25-39. PubMed ID: 23666688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in laboratory medicine in chronic myeloid leukemia].
    Miura A
    Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.